Divergence in μ and δ opioid receptor pharmacology in neurons and antinociceptive efficacy in neuropathic pain: Insights from MP135 and CYM51010
British Journal of Pharmacology · 2026
DOI: 10.1111/bph.70285 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2026. Verfasst von Perrine Inquimbert und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centre National de la Recherche Scientifique, Institut des Neurosciences Cellulaires et Intégratives UPR 3212, University of Strasbourg, Strasbourg, …. Hauptthemen laut MEDLINE: Neuralgia, Receptors, Opioid, delta, Receptors, Opioid, mu, Neurons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Unistra, NIDA NIH HHS, FRC Neurodon.
Abstract (Originalsprache)
Background and purpose Opioids targeting the μ opioid receptor remain largely ineffective in neuropathic pain conditions, emphasizing the need for novel therapeutic strategies. MP135 was reported to reduce thermal nociception in naive animals by activating μ‐δ opioid receptor heteromers. In this study, we compared its pharmacological profile and antinociceptive properties in naive and neuropathic conditions to those of the μ‐δ biased agonist CYM51010 and the μ opioid agonist morphine. Experimental approach Ligand affinity and activation of the G protein and β ‐arrestin pathways were determined using opioid receptors in their native environment. The impact of acute administration on thermal and mechanical nociceptive thresholds was evaluated in naive male and female mice. The impact on mechanical threshold and respiratory depression was also evaluated in mice with sciatic nerve injury. Pharmacological selectivity was established using μ or δ opioid receptor knock‐out mice. Key results The three drugs showed similar binding profile and activation of G protein‐dependent pathways. However, only MP135 and CYM51010 activated the β ‐arrestin pathway. In naive female mice, the drugs induced shorter thermal antinociception together with reduced maximal efficacy for morphine and MP135. In neuropathic conditions, morphine and MP135 were respectively poorly effective or ineffective whereas CYM51010 increased the mechanical threshold. The three drugs induced respiratory depression. Conclusion and implications The antinociceptive effect was receptor selective and affected by sex and neuropathic condition. This was unexpected based on the drug ex vivo pharmacological profiles and emphasizes the shortcomings of cell‐based approaches to reliably predict behavioural responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre National de la Recherche Scientifique, Institut des Neurosciences Cellulaires et Intégratives UPR 3212, University of Strasbourg, Strasbourg, France.
- Centre National de la Recherche Scientifique and University of Strasbourg, SMPMS-INCI, Mass Spectrometry Facilities of the Institut des Neurosciences Cellulaires et Intégratives, Strasbourg, France.
- Laboratoire d'Innovation Thérapeutique, UMR7200, CNRS, Université de Strasbourg, Illkirch, France.
- Centre National de la Recherche Scientifique, Plateforme de chimie biologique Intégrative de Strasbourg, ESBS, Illkirch, France.
- Center for Clinical Pharmacology, University of Health Sciences and Pharmacy at St Louis and Washington University School of Medicine, St. Louis, Missouri, USA.
- Centre National de la Recherche Scientifique, Chronobiotron UAR 3415, Strasbourg, France.
ORCID-Profile: Yannick Goumon, Susruta Majumdar, Dominique Massotte
Förderung
- Unistra
- NIDA NIH HHS
- FRC Neurodon
- FRC Neurodon - Rotary Club-Espoir en Tête
- Interdisciplinary Thematic Institute IMS
- Centre National de la Recherche Scientifique
- Université de Strasbourg
- IdEx Unistra
Zitieren
APA
Inquimbert, P., Fitterer, C., Hugel, S., Jesic, M., Goumon, Y., Andry, V., Schneider, S., Daubeuf, F., Faouzi, A., Doridot, S., Majumdar, S., Bihel, F., Schmitt, M., & Massotte, D. (2026). Divergence in μ and δ opioid receptor pharmacology in neurons and antinociceptive efficacy in neuropathic pain: Insights from MP135 and CYM51010. British Journal of Pharmacology. https://doi.org/10.1111/bph.70285
Vancouver
Inquimbert P, Fitterer C, Hugel S, Jesic M, Goumon Y, Andry V, et al. Divergence in μ and δ opioid receptor pharmacology in neurons and antinociceptive efficacy in neuropathic pain: Insights from MP135 and CYM51010. British Journal of Pharmacology. 2026. doi:10.1111/bph.70285
BibTeX
@article{Inquimbert2026,
author = {Inquimbert, Perrine and Fitterer, Chantal and Hugel, Sylvain and Jesic, Mila and Goumon, Yannick and Andry, Virgine and Schneider, Severine and Daubeuf, Francois and Faouzi, Abdelfattah and Doridot, Stephane and Majumdar, Susruta and Bihel, Frederic and Schmitt, Martine and Massotte, Dominique},
title = {Divergence in μ and δ opioid receptor pharmacology in neurons and antinociceptive efficacy in neuropathic pain: Insights from MP135 and CYM51010},
journal = {British Journal of Pharmacology},
year = {2026},
doi = {10.1111/bph.70285}
}
EUVIMED